BRIMONIDINE TARTRATE 0.25% / POTASSIUM AZELOYL DIGLYCINATE 8%
- Manufacturer
- Sincerus Florida, LLC
- Effective date
- 2019-05-15
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 20:28:45
Label at a glance#
ProductBRIMONIDINE TARTRATE 0.25% / POTASSIUM AZELOYL DIGLYCINATE 8%
Active ingredientBRIMONIDINE TARTRATE
Label structure4 sections
Label contents#
Full prescribing information#
Sincerus Florida, LLC. Advese reactions
Active, inactive
NDC 72934- 1027-2 BRIMONIDINE TARTRATE USP 0.25% . Gel 30gm
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| BRIMONIDINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20230503 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c6c0c444-a6ba-2fb5-a7bc-7f0443fa5791 | Product name | 4 | 20251208 |
| 8ec6541e-9842-115f-62bf-f7c9ab3aeddb | Product name | 3 | 20250805 |
| 39b7fcf4-8865-6d40-d24d-9b8c28bd6345 | Product name | 5 | 20250123 |
| c93ffd9a-5bad-44d8-b5e5-16ef4d2fee72 | Product name | 1 | 20220316 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 72934-1027-2 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-4f64-a910-e053-dadaa90a0b85 | BRIMONIDINE TARTRATE 0.25% / POTASSIUM AZELOYL DIGLYCINATE 8% |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72934-1027-2 | BRIMONIDINE TARTRATE 0.25% / POTASSIUM AZELOYL DIGLYCINATE 8% | 30 g in 1 BOTTLE, PUMP | GEL | 30 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72934-1027 | BRIMONIDINE TARTRATE 0.25% / POTASSIUM AZELOYL DIGLYCINATE 8% GEL [SINCERUS FLORIDA, LLC] | 1 | Legacy NDC, 1 package rows | 20190516_88ef2cc1-1855-9606-e053-2995a90a2e67.zip |
Products#
Every source-derived product name is available through these pages.
- BRIMONIDINE TARTRATE 0.25% / POTASSIUM AZELOYL DIGLYCINATE 8%
- BRIMONIDINE TARTRATE
- BRIMONIDINE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 72934-1027 | 72934-1027-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BRIMONIDINE TARTRATE | 4S9CL2DY2H | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 88ef2cc1-1856-9606-e053-2995a90a2e67 | 88ef2cc1-1855-9606-e053-2995a90a2e67 | 2019-05-15 | Adverse reactions | 88ef2cc1-1856-9606-e053-2995a90a2e67 88ef2cc1-1855-9606-e053-2995a90a2e67 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


